Established in 2008, Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators.
As a shared enterprise of the University, Harvard Catalyst is funded by the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) Program (grant UL1 TR001102), Harvard University, and its affiliated healthcare centers.
Resources are freely available to all Harvard faculty, regardless of institutional affiliation or academic degree.
Here are just a few of the resources they offer:
Find collaborators:
Harvard Catalyst Profiles is a nationally recognized search tool to find Harvard faculty by key terms and specializations.
Conduct a clinical study:
In-patient and out-patient facilities at BCH, BIDMC, BWH, and MGH; research nursing; coordination; nutrition; laboratory assays and other clinical research resources.
Enter a training program:
Advanced mentored training and research (KL2); a two-year master’s degree program; and Grant Review and Support Program (GRASP).
Expedite a multi-site study:
Use SMART IRB to move your study forward.
Get advice:
Consultations are available on biostatistics and research design, population health research, regulatory, and bioinformatics.
Receive pilot funding:
Opportunities have included childhood obesity, health disparities, advanced imaging, and advanced microscopy. Check pilot funding page for new opportunities.
Use Harvard Catalyst informatics tools:
Access de-identified patient data with SHRINE, and share research resources with other labs using eagle-i (eagle-i.net).
Take a course:
A complete portfolio of clinical and translational research education is offered throughout the year.
About the Mass General Research Institute
Research at Massachusetts General Hospital is interwoven through more than 30 different departments, centers and institutes. Our research includes fundamental, lab-based science; clinical trials to test new drugs, devices and diagnostic tools; and community and population-based research to improve health outcomes across populations and eliminate disparities in care.
Support our Research
Leave a Comment